机器人辅助与开放根治性膀胱切除术并发症及再入院率比较:随机RAZOR临床试验结果
基于RAZOR多中心、开放标签、3期非劣效性随机试验的方案符合人群,比较机器人辅助根治性膀胱切除术(RARC)与开放根治性膀胱切除术(ORC)的并发症和再入院差异。RARC组150例与ORC组152例的总体及主要并发症率无显著差异,90天再入院率分别为24.1%和23.1%,1年再入院率分别为29.5%和28.5%(P=.80)。简化衰弱指数≥3是主要并发症和再入院的显著预测因素。
要点
- RARC与ORC的总体及主要并发症率无显著差异。
- 90天再入院率RARC组24.1% vs ORC组23.1%,1年再入院率RARC组29.5% vs ORC组28.5%(P=.80)。
- 简化衰弱指数≥3是主要并发症和再入院的显著预测因素。
核心结论
- ORC与RARC在主要并发症和再入院率方面无显著差异。
- 患者衰弱是这些结局的重要预测因素,需要特别注意确保合适的患者选择和术前准备。
研究设计与样本
- 研究使用RAZOR随机试验的方案符合人群数据,该试验为多中心、开放标签、3期非劣效性临床试验。
- RAZOR于2011年至2014年间在美国15个学术医学中心入组,中位随访时间为2年。
- 比较采用Clavien-Dindo分类评估的90天并发症,以及术后90天和1年的再入院率,并采用多变量逻辑回归分析确定主要并发症和术后再入院的预测因素。
主要发现
- RARC组(n=150)与ORC组(n=152)基线特征相似,总体及主要并发症率无显著差异。
- 简化衰弱指数≥3是90天内主要并发症的显著预测因素(HR 4.22,95%CI 2.67-6.66,P<.0001)。
- 90天再入院率RARC组为24.1%,ORC组为23.1%;1年再入院率RARC组为29.5%,ORC组为28.5%(P=.80)。
- 简化衰弱指数≥3是90天再入院的显著预测因素(子分布HR 4.43,95%CI 1.75-11.2,P=.002)。
- 简化衰弱指数≥3是1年再入院的显著预测因素(子分布HR 5.28,95%CI 2.22-12.6,P<.001)。
临床怎么用
- 原文结论指出,患者衰弱是主要并发症和再入院的重要预测因素,需要特别注意确保合适的患者选择和术前准备。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We assessed differences in complications and readmissions between robot-assisted radical cystectomy (RARC) and open radical cystectomy (ORC). MATERIALS AND METHODS: This study uses data from the per-protocol population of the Randomized Robotic-Assisted vs Open Radical Cystectomy (RAZOR) study, a multicenter, open-label, phase 3, noninferiority clinical trial. RAZOR enrolled across 15 academic medical centers in the United States between 2011 and 2014. The median follow-up was 2 years. Complications up to 90 days using the Clavien-Dindo classification, and readmissions at 90 days and 1 year postoperatively were compared. Multivariable logistic regression analyses were performed to determine any predictors of major complications and of postsurgery readmission. RESULTS: Baseline characteristics were similar, and there was no significant difference in overall and major complication rates between RARC (n = 150) and ORC (n = 152) arms. Simplified frailty index ≥ 3 (HR, 4.22, 95% CI, 2.67-6.66, P < .0001) was a significant predictor of major complications within 90 days. Readmission rates at 90 days were 24.1% for RARC and 23.1% for ORC, and readmission rates at 1 year were 29.5% for RARC and 28.5% for ORC (P = .80). Simplified frailty index ≥ 3 was a significant predictor of readmission at both time points (subdistribution HR 4.43, 95% CI, 1.75-11.2, P = .002 at 90 days and subdistribution HR, 5.28, 95% CI, 2.22-12.6, P < .001, at 1 year). CONCLUSIONS: No significant differences in major complications and readmission rates between ORC and RARC were noted. Patient frailty was an important predictor of these outcomes, and special attention needs to be taken in ensuring appropriate patient selection and preoperative preparation. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01157676.
引用
- Venkatramani V, Reis IM, Gonzalgo ML, et al. Comparison of Complication and Readmission Rates Between Robot-Assisted and Open Radical Cystectomy: Results From the Randomized RAZOR Clinical Trial. J Urol. 2025. PMID: 40080805. doi:10.1097/JU.0000000000004497
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。